Cytodifferentiation, but not resolution, of embryonal rhabdomyosarcoma

Pediatric and Developmental Pathology

Volumn 7, Issue 4, 2004, Pages 398-399

  Nigro, Kelly Grove ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ANTINEOPLASTIC AGENT; DESMIN; MYOD PROTEIN;

ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; CELL DIFFERENTIATION; CHILDHOOD CANCER; COMPUTER ASSISTED TOMOGRAPHY; CYTOPLASM; DIAGNOSTIC IMAGING; EMBRYONAL RHABDOMYOSARCOMA; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NEEDLE BIOPSY; PRESCHOOL CHILD; PRIORITY JOURNAL; SPINDLE CELL; URINE RETENTION;

EID: 4344689547     PISSN: 10935266     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10024-004-1016-x     Document Type: Article

References (7)

1. Willis RA. The Borderland of Embryology and Pathology. London: Butterworth and Co, 1958;410-429.
2. Parham DM. Pathologic classification of rhabdomyosarcomas and correlations with molecular studies. Mod Pathol 2001;14:506-514.
3. Parham DM. Small round cell tumors of childhood: importance of cytogenetics in prognosis and diagnosis. Adv Pathol Lab Med 1995;8:223-245.
4. Thorner PS, Squire JA (2003) Molecular genetics in the diagnosis and prognosis of solid pediatric tumors. In: Perspectives in Pediatric Pathology. Molecular Mechanisms in Development and in Pediatric Pathology. Augusta, GA: Society for Pediatric Pathology, pp 187-215.
5. Molenaar WM, Oosterhuis JW, Kamps WA. Cytologic " differentiation" in childhood rhabdomyosarcomas following polychemotherapy. Hum Pathol 1984;15:973-979.
6. Lowichik A, Zhou H, Pysher TJ, Smith L, Lemons R, Coffin CM. Therapy associated changes in childhood tumors. Adv Anat Pathol 2000;7:341-359.
7. Coffin CM, Rulon J, Smith L, Bruggers C, White F. Pathologic features of rhabdomyosarcoma before and after treatment: a clinicopathologic and immunohistochemical analysis. Mod Pathol 1997;10:1175-1187.